1. Market Research
  2. > Chemical Market Trends
  3. > Fatty Acid Amide Hydrolase (FAAH) Inhibitors -Pipeline Insights, 2016


DelveInsight’s, “Fatty Acid Amide Hydrolase (FAAH) Inhibitors-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Fatty Acid Amide Hydrolase (FAAH) Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Fatty Acid Amide Hydrolase (FAAH) Inhibitors. DelveInsight’s Report also assesses the Fatty Acid Amide Hydrolase (FAAH) Inhibitors therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope
- The report provides competitive pipeline landscape of Fatty Acid Amide Hydrolase (FAAH) Inhibitors
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Fatty Acid Amide Hydrolase (FAAH) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Fatty Acid Amide Hydrolase (FAAH) Inhibitors and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Fatty Acid Amide Hydrolase (FAAH) Inhibitors -Pipeline Insights, 2016

- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Overview
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Disease Associated
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Pipeline Therapeutics
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Therapeutics under Development by Companies
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Filed and Phase III Products
- Comparative Analysis
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Phase II Products
- Comparative Analysis
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Phase I and IND Filed Products
- Comparative Analysis
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors - Discontinued Products
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors - Dormant Products
- Companies Involved in Therapeutics Development for Fatty Acid Amide Hydrolase (FAAH) Inhibitors
- Appendix
- Methodology
- Contact Us
- Disclaimer


List of Tables

- Number of Products under Development for Fatty Acid Amide Hydrolase (FAAH) Inhibitors by Therapy Area, 2016
- Number of Products under Development for Fatty Acid Amide Hydrolase (FAAH) Inhibitors, 2016
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2016
- Comparative Analysis Phase II Products, 2016
- Comparative Analysis Phase I and IND Filed Products, 2016
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
- Drug Candidates Profiles
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Assessment by Monotherapy Products
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Assessment by Combination Products
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Assessment by Route of Administration
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Assessment by Stage and Route of Administration
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Assessment by Molecule Type
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Assessment by Stage and Molecule Type
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Therapeutics - Discontinued Products
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Therapeutics - Dormant Products
- Products under Development by Companies, 2016

List of Figures

- Number of Products under Development for Fatty Acid Amide Hydrolase (FAAH) Inhibitors by Therapy Area, 2016
- Number of Products under Development for Fatty Acid Amide Hydrolase (FAAH) Inhibitors, 2016
- Filed and Phase III Products, 2016
- Phase II Products, 2016
- Phase I and IND Filed Products, 2016
- Discovery and Pre-Clinical Stage Products, 2016
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Assessment by Monotherapy Products
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Assessment by Combination Products
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Assessment by Route of Administration
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Assessment by Stage and Route of Administration
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Assessment by Molecule Type
- Fatty Acid Amide Hydrolase (FAAH) Inhibitors Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Fatty Acid Methyl Ester Market by Type, Application, Region - Global Forecast to 2021

Fatty Acid Methyl Ester Market by Type, Application, Region - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

“The global fatty acid methyl ester market size is projected to reach USD 22.13 billion by 2021” The global fatty acid methyl ester market is projected to reach USD 22.13 billion by 2021, from USD ...

Oleochemicals Market Analysis By Product And Segment Forecasts To 2024

Oleochemicals Market Analysis By Product And Segment Forecasts To 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The global oleochemicals market is expected to reach USD 30.15 billion by 2024, according to a new report by Grand View Research, Inc. Growing biochemical product demand in various consumer applications ...

9-Decanoic Acid Methyl Ester Market Analysis By Application and Segment Forecasts to 2025

9-Decanoic Acid Methyl Ester Market Analysis By Application and Segment Forecasts to 2025

  • $ 4950
  • Industry report
  • September 2016
  • by Grand View Research

The global 9-decanoic acid methyl ester market is expected to reach USD 240.0 million by 2025, according to a new report by Grand View Research, Inc. Rising awareness regarding the use of green chemicals ...


Download Unlimited Documents from Trusted Public Sources

Oleochemicals Markets in the US

  • November 2016
    41 pages
  • Oleochemicals  

    Oil  

    Infant Formula  

  • United States  

View report >

Oleochemicals Industry in Laos

  • October 2016
    8 pages
  • Oleochemicals  

    Gas  

  • Laos  

View report >

Oleochemicals Supply in the US

  • October 2016
    11 pages
  • Oleochemicals  

  • United States  

View report >

Related Market Segments :

Oleochemicals

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.